SUBSCRIBE
SUBSCRIBE

BridgeBio LLC

NEWS
Biotech Bay
BridgeBio Launches QED Therapeutics With $65M and an Abandoned Novartis Cancer Program
BridgeBio stepped in to take over the drug and also launch a subsidiary, QED Therapeutics, to drive the development of infigratinib.
January 30, 2018
 · 
2 min read
 · 
Alex Keown
Biotech Bay
BioPharm Executive: Money Talk
Venture capital is hopping, attracted to some of the past several years’ successes.
October 14, 2017
 · 
1 min read
 · 
Karl Thiel
3 Biotechs That Could be Taken Out This Quarter
Business
Bay Area Startup BridgeBio Quietly Snags $135 Million From a Bunch of Wall Street Firms
September 13, 2017
 · 
2 min read
3 Biotechs That Could be Taken Out This Quarter
Business
Another Biotech is Born as Bay Area’s BridgeBio Pharma Launches Eidos Therapeutics With $27 Million
April 27, 2017
 · 
2 min read
Load More
AWARDS
  • 2026 - Best Places to Work - Badge (1).png
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Press Releases
BBOT to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 17, 2025
 · 
1 min read
Press Releases
BridgeBio to Participate in December 2025 Investor Conferences
November 26, 2025
 · 
1 min read
Press Releases
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - November 19, 2025
November 20, 2025
 · 
1 min read
Press Releases
BBOT to Participate in Upcoming December Investor Healthcare Conferences
November 19, 2025
 · 
1 min read
Press Releases
Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations
November 10, 2025
 · 
12 min read
Press Releases
BridgeBio to Participate in November 2025 Investor Conferences
November 5, 2025
 · 
1 min read
Press Releases
BridgeBio to Present Data from the Overall ATTR-CM Variant and V142I (V122I) Populations from ATTRibute-CM at the AHA Scientific Sessions 2025
November 4, 2025
 · 
3 min read
Press Releases
BBOT Announces Poster Presentations at the San Antonio Breast Cancer Symposium (SABCS)
October 31, 2025
 · 
2 min read
Press Releases
BridgeBio Reports Third Quarter 2025 Financial Results and Business Updates
October 30, 2025
 · 
30 min read
Press Releases
BridgeBio Reports Positive Phase 3 Topline Results for Encaleret in Patients with Autosomal Dominant Hypocalcemia Type 1
October 29, 2025
 · 
9 min read
Load More